# UNIVERSITY OF CALIFORNIA, SAN FRANCISCO: Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO |
| Location | SAN FRANCISCO, CA |
| Project | Primary Immune Deficiency Treatment Consortium (PIDTC): A resource to drive scientific and clinical advances related to the treatment of inborn errors of immunity |
| Project number | 5R24AI184316-03 |
| Mechanism | R24 |
| Institute | National Institute of Allergy and Infectious Diseases |
| Award | $1,724,763 |
| Awarded | 2026-09-17 |
| Project period | 2024-09-03 to 2029-08-31 |
| UEI | KMH5K9V7S518 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11392289). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.